C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 473/34 (2006.01) A61K 31/52 (2006.01) A61K 31/5377 (2006.01) A61K 31/541 (2006.01) A61P 25/00 (2006.01) A61P 25/04 (2006.01) A61P 25/28 (2006.01) A61P 25/30 (2006.01) A61P 25/36 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2563123
Selective antagonists of A2A adenosine receptors are provided. The novel A2A blockers are useful for the treatment of Parkinson's disease and other diseases.
L'invention concerne des antagonistes sélectifs des récepteurs A2A de l'adénosine. Les nouveaux inhibiteurs de A2A sont utiles pour le traitement de la maladie de Parkinson et d'autres maladies.
Beauglehole Anthony
Rieger Jayson M.
Thompson Robert D.
Adenosine Therapeutics Llc
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Trovis Pharmaceuticals Llc
LandOfFree
Selective antagonists of a2a adenosine receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective antagonists of a2a adenosine receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective antagonists of a2a adenosine receptors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1916924